Cengiz Ovalı1, Aykut Şahin1. 1. Department of Cardiovascular Surgery, Medical School of Eskisehir Osmangazi University (ESOGU), Eskisehir, Turkey.
Abstract
PURPOSE: To determine to what extent chronic obstructive pulmonary disease (COPD) affects mortality and morbidity rates in patients treated with off-pump coronary artery bypass graft (CABG). METHODS: A total of 321 patients treated with off-pump CABG were included in the present study. Of the 321 patients, 46 patients had COPD and they were designated as Group 1 and the remaining 275 patients did not have COPD and they were considered as Group 2. We compared the data obtained from the patients in both groups. RESULTS: While preoperative spirometry values and arterial blood gas oxygen saturation levels were significantly lower, the partial values of carbon dioxide were higher in Group 1. Likewise, extubation time, the amount of drainage and blood transfusion, inotropic support, prolonged intubation, pulmonary complications, the use of bronchodilators, and steroids were statistically higher in Group 1 when compared with Group 2. Overall, there was no marked difference between the two groups in terms of mortality incidence. CONCLUSION: We found similar morbidity and mortality rates among the patients with COPD and without COPD when they were treated with off-pump CABG. Therefore, the present results indicate that the presence of COPD is not associated with in-hospital mortality or severe morbidity post-CABG by off-pump approach.
PURPOSE: To determine to what extent chronic obstructive pulmonary disease (COPD) affects mortality and morbidity rates in patients treated with off-pump coronary artery bypass graft (CABG). METHODS: A total of 321 patients treated with off-pump CABG were included in the present study. Of the 321 patients, 46 patients had COPD and they were designated as Group 1 and the remaining 275 patients did not have COPD and they were considered as Group 2. We compared the data obtained from the patients in both groups. RESULTS: While preoperative spirometry values and arterial blood gas oxygen saturation levels were significantly lower, the partial values of carbon dioxide were higher in Group 1. Likewise, extubation time, the amount of drainage and blood transfusion, inotropic support, prolonged intubation, pulmonary complications, the use of bronchodilators, and steroids were statistically higher in Group 1 when compared with Group 2. Overall, there was no marked difference between the two groups in terms of mortality incidence. CONCLUSION: We found similar morbidity and mortality rates among the patients with COPD and without COPD when they were treated with off-pump CABG. Therefore, the present results indicate that the presence of COPD is not associated with in-hospital mortality or severe morbidity post-CABG by off-pump approach.
Authors: Samer A M Nashef; François Roques; Linda D Sharples; Johan Nilsson; Christopher Smith; Antony R Goldstone; Ulf Lockowandt Journal: Eur J Cardiothorac Surg Date: 2012-02-29 Impact factor: 4.191
Authors: Rafael García Fuster; José A Montero Argudo; Oscar Gil Albarova; Fernando Hornero Sos; Sergio Cánovas López; María Bueno Codoñer; José A Buendía Miñano; Ignacio Rodríguez Albarran Journal: Eur J Cardiothorac Surg Date: 2005-12-20 Impact factor: 4.191
Authors: David M Shahian; Sean M O'Brien; Shubin Sheng; Frederick L Grover; John E Mayer; Jeffrey P Jacobs; Jocelyn M Weiss; Elizabeth R Delong; Eric D Peterson; William S Weintraub; Maria V Grau-Sepulveda; Lloyd W Klein; Richard E Shaw; Kirk N Garratt; Issam D Moussa; Cynthia M Shewan; George D Dangas; Fred H Edwards Journal: Circulation Date: 2012-02-23 Impact factor: 29.690
Authors: Saurabh Sanon; Vei-Vei Lee; MacArthur A Elayda; Sreedevi Gondi; James J Livesay; George J Reul; James M Wilson Journal: Tex Heart Inst J Date: 2013
Authors: Rutao Wang; Mariusz Tomaniak; Kuniaki Takahashi; Chao Gao; Hideyuki Kawashima; Hironori Hara; Masafumi Ono; David van Klaveren; Robert-Jan van Geuns; Marie-Claude Morice; Piroze M Davierwala; Michael J Mack; Adam Witkowski; Nick Curzen; Sergio Berti; Francesco Burzotta; Stefan James; Arie Pieter Kappetein; Stuart J Head; Daniel J F M Thuijs; Friedrich W Mohr; David R Holmes; Ling Tao; Yoshinobu Onuma; Patrick W Serruys Journal: Clin Res Cardiol Date: 2021-03-12 Impact factor: 5.460